130 filings
10-K/A
2023 FY
ELTX
Elicio Therapeutics Inc.
Annual report (amended)
29 Apr 24
7:00am
8-K
ELTX
Elicio Therapeutics Inc.
5 Apr 24
Other Events
4:33pm
S-8
ELTX
Elicio Therapeutics Inc.
29 Mar 24
Registration of securities for employees
3:28pm
S-3
ELTX
Elicio Therapeutics Inc.
Shelf registration
29 Mar 24
3:26pm
10-K
2023 FY
ELTX
Elicio Therapeutics Inc.
Annual report
29 Mar 24
1:58pm
8-K
jt092 4t34wsvshc9bt
29 Mar 24
Results of Operations and Financial Condition
8:35am
D
sje2ymnq6aqzzmq
28 Mar 24
$6.00 mm in options / securities to be acquired, sold $6.00 mm, 1 investor
6:15pm
8-K
sunuadv3kgz
18 Mar 24
Entry into a Material Definitive Agreement
8:05am
8-K
juexfs3wtfsrneim
2 Feb 24
Departure of Directors or Certain Officers
8:51am
8-K
wri59dk
17 Jan 24
Other Events
8:35am
8-K
oiqw1qafw3m tn4
16 Jan 24
Other Events
7:59am
8-K
bihbs7y
9 Jan 24
Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutic’s AMPLIFY-201 Phase 1 Solid Tumor Study of ELI-002
8:11am
D
5fuh h75e
5 Jan 24
$7.05 mm in equity, sold $7.05 mm, 1 investor
4:05pm
8-K
n3v7uj7c7fvbs9
22 Dec 23
Entry into a Material Definitive Agreement
9:06am
8-K
c84j7
9 Nov 23
Results of Operations and Financial Condition
4:41pm
8-K
n4mmaaeimkp wafek
3 Nov 23
Other Events
5:10pm
8-K
a57k vl2mn4
20 Oct 23
Departure of Directors or Certain Officers
7:58am
8-K
oxae9lgfm6e75p1zs
12 Oct 23
Departure of Directors or Certain Officers
7:59am
8-K
mgrszgavzqznz26q5qb
27 Sep 23
Other Events
5:41pm